TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Miltenyi Biotec Norden AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
13,537
|
13,595
|
11,648 |
| Financial expenses |
3
|
0
|
2 |
| Earnings before taxes |
1,241
|
984
|
1,100 |
| EBITDA |
1,457
|
1,183
|
1,216 |
| Total assets |
6,630
|
5,641
|
4,779 |
| Current assets |
6,113
|
4,915
|
4,085 |
| Current liabilities |
3,946
|
3,878
|
3,787 |
| Equity capital |
2,684
|
1,763
|
992 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
21
|
22
|
19 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
40.5%
|
31.3%
|
20.8% |
| Turnover per employee |
645
|
618
|
613 |
| Profit as a percentage of turnover |
9.2%
|
7.2%
|
9.4% |
| Return on assets (ROA) |
18.8%
|
17.4%
|
23.1% |
| Current ratio |
154.9%
|
126.7%
|
107.9% |
| Return on equity (ROE) |
46.2%
|
55.8%
|
110.9% |
| Change turnover |
405
|
1,913
|
2,233 |
| Change turnover % |
3%
|
16%
|
24% |
| Chg. No. of employees |
-1
|
3
|
1 |
| Chg. No. of employees % |
-5%
|
16%
|
6% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.